Nature Communications (Oct 2024)

Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1

  • Hisano Yajima,
  • Yuki Anraku,
  • Yu Kaku,
  • Kanako Terakado Kimura,
  • Arnon Plianchaisuk,
  • Kaho Okumura,
  • Yoshiko Nakada-Nakura,
  • Yusuke Atarashi,
  • Takuya Hemmi,
  • Daisuke Kuroda,
  • Yoshimasa Takahashi,
  • Shunsuke Kita,
  • Jiei Sasaki,
  • Hiromi Sumita,
  • The Genotype to Phenotype Japan (G2P-Japan) Consortium,
  • Jumpei Ito,
  • Katsumi Maenaka,
  • Kei Sato,
  • Takao Hashiguchi

DOI
https://doi.org/10.1038/s41467-024-52808-2
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Since 2019, SARS-CoV-2 has undergone mutations, resulting in pandemic and epidemic waves. The SARS-CoV-2 spike protein, crucial for cellular entry, binds to the ACE2 receptor exclusively when its receptor-binding domain (RBD) adopts the up-conformation. However, whether ACE2 also interacts with the RBD in the down-conformation to facilitate the conformational shift to RBD-up remains unclear. Herein, we present the structures of the BA.2.86 and the JN.1 spike proteins bound to ACE2. Notably, we successfully observed the ACE2-bound down-RBD, indicating an intermediate structure before the RBD-up conformation. The wider and mobile angle of RBDs in the up-state provides space for ACE2 to interact with the down-RBD, facilitating the transition to the RBD-up state. The K356T, but not N354-linked glycan, contributes to both of infectivity and neutralizing-antibody evasion in BA.2.86. These structural insights the spike-protein dynamics would help understand the mechanisms underlying SARS-CoV-2 infection and its neutralization.